Virax Biolabs Group Ltd. Class A had a revenue of 4.95K in the quarter ending Sep 30, 2024, with -93.80%. This bring the company's revenue in the last twelve months to 84.87K, Increased -45.74%. In the fiscal year ending Mar 31, 2024, Virax Biolabs Group Ltd. Class A had annual revenue of 156.42K with ― growth.